Inventor · disambiguated record
Philip M. Murphy
Also filed as: MURPHY PHILIP · MURPHY PHILIP M
10 granted patents·7 pending applications·116 citations·filing 1991–2025
88Inventor score
Files withUS HEALTH6CHILDRENS MEDICAL CT CORP2US ARMY2COMBADIERE CHRISTOPHE1GOV T OF THE U S A AS REPRESEN1
Top patents by PatentIndex Score
17 records- 0187US7151087B2CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infectionUS DEPT OF HEALTH AND HUMAN RE·Filed 2003·Granted Dec 19, 2006·17 cites·8 claims
- 0279US5652133ACloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptorUS ARMY·Filed 1993·Granted Jul 29, 1997·47 cites·12 claims
- 0378US6808877B2Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infectionUS HEALTH·Filed 2002·Granted Oct 26, 2004·11 cites·9 claims
- 0470US2008241167A1Cc chemokine receptor 5 dna, new animal models and therapeutic agents for hiv infectionGOV T OF THE U S A AS REPRESEN·Filed 2008·Application pending·0 cites
- 0567US2025345450A1Antibody-mediated conditioning with immunosuppression to enable allogeneic transplantationCHILDRENS MEDICAL CT CORP·Filed 2025·Application pending·0 cites
- 0663US6830893B2T20/DP178 is an activator of human phagocyte formyl peptide receptorsUS HEALTH·Filed 2001·Granted Dec 14, 2004·2 cites·5 claims
- 0763US5374506AAmino acid sequence for a functional human interleukin-8 receptorUS ARMY·Filed 1991·Granted Dec 20, 1994·20 cites·3 claims
- 0859US7374872B2CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infectionUS HEALTH·Filed 2006·Granted May 20, 2008·0 cites·9 claims
- 0957US12485186B2Antibody-mediated conditioning with immunosuppression to enable allogeneic transplantationCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Dec 2, 2025·0 cites·2 claims
- 1055US8198042B2CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infectionCOMBADIERE CHRISTOPHE·Filed 2004·Granted Jun 12, 2012·0 cites·20 claims
- 1154US2003195348A1CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infectionUS HEALTH·Filed 2003·Application pending·0 cites
- 1254US2011117101A1Cc chemokine receptor 5 dna, new animal models and therapeutic agents for hiv infectionUS SECRETARY DEPT OF HEALTH AND·Filed 2011·Application pending·0 cites
- 1353US6383746B1Functional promoter for CCR5US HEALTH·Filed 1998·Granted May 7, 2002·19 cites·30 claims
- 1450US2005085629A1Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA)Filed 2004·Application pending·0 cites
- 1546US2005130890A1Amyloid beta is a ligand for FPR class receptorsFiled 2004·Application pending·0 cites
- 1643US2003120037A1Utilization of FPRL1 as a functional receptor by serum amyloid a (SAA)Filed 2002·Application pending·0 cites
- 1728US11278572B2Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cellsUS HEALTH·Filed 2015·Granted Mar 22, 2022·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Philip M. Murphy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →